Novo Nordisk A/S
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority (77.1%) of its voting shares.
Beyond's analysis on Novo Nordisk A/S
- — Novo Nordisk insider trading disclosure under EU market abuse rules signals routine compliance activity
- — Novo Nordisk launches a EU‑compliant share repurchase programme to return capital to shareholders
Recent news mentioning Novo Nordisk A/S
- — Hims & Hers Health (HIMS) & Novo Nordisk A/S (NVO): Two Weight-Loss Pill Players Just Got Punished for Growing Fast
- — Eli Lilly and Company (LLY)’s Weight-Loss Pill Just Won Its First Race in Europe. Novo Nordisk A/S (NVO) Still Has a Head Start
- — Is Scholar Rock Holding Corporation (SRRK) Better Positioned than Novo Nordisk A/S (NVO) After Recent Setbacks?
- — Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market?
- — Novo Nordisk A/S - share repurchase programme
- — Novo Nordisk A/S Q2 Earnings Call Highlights
- — Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
- — Novo Nordisk A/S - share repurchase programme
- — Novo Nordisk A/S - share repurchase programme
- — Jim Cramer Wants Novo Nordisk A/S (NYSE:NVO) To Compete With Eli Lilly In The Market & Not The Courts